Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
8.17
+0.09 (1.11%)
Aug 14, 2026, 4:00 PM EDT - Market closed
Kyverna Therapeutics Employees
Kyverna Therapeutics had 129 employees as of March 31, 2026. The number of employees increased by 10 or 8.40% compared to the same quarter last year.
Employees
129
Change
10
Growth
8.40%
Revenue / Employee
n/a
Profits / Employee
-$1,183,240
Market Cap
505.26M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 129 | 10 | 8.40% |
| Dec 31, 2025 | 130 | 18 | 16.07% |
| Sep 30, 2025 | 129 | 10 | 8.40% |
| Jun 30, 2025 | 129 | 17 | 15.18% |
| Mar 31, 2025 | 119 | 19 | 19.00% |
| Dec 31, 2024 | 112 | 16 | 16.67% |
| Sep 30, 2024 | 119 | 30 | 33.71% |
| Jun 30, 2024 | 112 | 23 | 25.84% |
| Mar 31, 2024 | 100 | - | - |
| Dec 31, 2023 | 96 | - | - |
| Sep 30, 2023 | 89 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MapLight Therapeutics | 133 |
| Adlai Nortye | 109 |
| C4 Therapeutics | 104 |
| OmniAb | 89 |
| Rezolute | 68 |
| Contineum Therapeutics | 51 |
| Zura Bio | 40 |
| Entera Bio | 22 |
KYTX News
- 3 days ago - Kyverna Therapeutics reports Q2 EPS (63c), consensus (68c) - TheFly
- 3 days ago - Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results - GlobeNewsWire
- 3 days ago - Kyverna Therapeutics Earnings release: Q2 2026 - Filings
- 3 days ago - Kyverna Therapeutics Quarterly report: Q2 2026 - Filings
- 3 days ago - Kyverna Therapeutics Slides: Corporate presentation - Filings
- 18 days ago - Kyverna Therapeutics, ElevateBio announce miv-cel manufacturing agreement - TheFly
- 18 days ago - Kyverna Therapeutics and ElevateBio Enter into Commercial Manufacturing and Supply Agreement for Miv-cel - GlobeNewsWire
- 7 weeks ago - Kyverna Therapeutics appoints Ritesh Srivastava chief legal, compliance officer - TheFly